2014
DOI: 10.1021/ja503270n
|View full text |Cite
|
Sign up to set email alerts
|

A Superfluorinated Molecular Probe for Highly Sensitive in Vivo19F-MRI

Abstract: (19)F-MRI offers unique opportunities to image diseases and track cells and therapeutic agents in vivo. Herein we report a superfluorinated molecular probe, herein called PERFECTA, possessing excellent cellular compatibility, and whose spectral properties, relaxation times, and sensitivity are promising for in vivo (19)F-MRI applications. The molecule, which bears 36 equivalent (19)F atoms and shows a single intense resonance peak, is easily synthesized via a simple one-step reaction and is formulated in water… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
155
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 116 publications
(160 citation statements)
references
References 19 publications
(16 reference statements)
5
155
0
Order By: Relevance
“…It should also be noted that because of the slow clearance kinetics of the crown ether used in this study (30), other PFCs might be more suitable for human applications. PFCs with a single resonance, such as perfluoropolyether (34) or "Perfecta" (35), might have different kinetics and allow for fewer injections, although this remains to be tested. Furthermore, given that the voxel size in humans is often more than two orders of magnitude larger than that used in EXPERIMENTAL STUDIES: Fluorine MR Imaging of Inflammation in Atherosclerotic Plaque in Vivo van Heeswijk et al mice here (up to 2 3 2 3 8 mm 3 or 32 mL vs 0.22 mL used in this study), a smaller dose may in fact be sufficient for initial plaque macrophage visualization in human carotid arteries.…”
Section: Experimental Studiesmentioning
confidence: 99%
“…It should also be noted that because of the slow clearance kinetics of the crown ether used in this study (30), other PFCs might be more suitable for human applications. PFCs with a single resonance, such as perfluoropolyether (34) or "Perfecta" (35), might have different kinetics and allow for fewer injections, although this remains to be tested. Furthermore, given that the voxel size in humans is often more than two orders of magnitude larger than that used in EXPERIMENTAL STUDIES: Fluorine MR Imaging of Inflammation in Atherosclerotic Plaque in Vivo van Heeswijk et al mice here (up to 2 3 2 3 8 mm 3 or 32 mL vs 0.22 mL used in this study), a smaller dose may in fact be sufficient for initial plaque macrophage visualization in human carotid arteries.…”
Section: Experimental Studiesmentioning
confidence: 99%
“…To a stirring mixture of diol 5 (41.0 g, 76.5 mmol) and K 2 CO 3 (26.4 g, 191.0 mmol) 12 in DMF (300 mL) at rt was added MeI (11.9 mL,27.1 g,190.8 mmol 13 (m), 83. 8,89.8,122.2 (q,J = 288.5 Hz),124.7,128.1,129.6,133.2;19 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 14 bromide 9 as an example). 1,32.4,34.2,54.3,61.7,65.7,122.5 (q,J = 287.5 Hz),125.6,126.4,129.3,129.5,130.0,130.3,143.0,144.0 33.9,34.0,54.4...…”
Section: Methodsmentioning
confidence: 99%
“…1 However, it is a very challenging task to image a drug in vivo with 19 F MRI because it has such a low sensitivity that a high 19 F concentration, a typical concentration of 89 mM for an example, 8 is generally required which is far beyond the in vivo concentration of most drugs. In addition, the 19 F NMR signal splitting and relatively long relaxation times of perfluorocarbons emulsion-based 19 F MRI agents, which are the most used imaging agents for 19 F MRI, further deteriorates the sensitivity of 19 F MRI.…”
Section: Introductionmentioning
confidence: 99%
“…Alternatively, 19 F MRI holds several unique advantages such as low endogenous background signals, high signal-to-noise ratio (SNR), 100% natural isotopic abundance, relatively high sensitivity (83% of proton) and broad range of chemical shifts. [26][27][28][29] To date, some exogenous contrast agents such as molecular probes with a number of equivalent fluorine atoms, [27,[30][31][32][33][34][35] polymeric tracers containing high numbers of fluorine atoms, [28,[36][37][38][39][40][41][42] and fluorinated metallic nanoparticles [43][44][45][46] have been developed and employed for 19 F MRI. Despite great successes, it is highly desirable and still challenging to develop suitable 19 F MRI contrast agents with satisfied performance as well as multi-modalities.…”
Section: Introductionmentioning
confidence: 99%